Cerebrospinal Fluid Leak Clinical Trial
Official title:
A Multicenter, Retrospective, Post-Market Clinical Follow-Up Study to Evaluate the Performance and Safety of Suturable DuraGen™
The primary goal of this study is to retrospectively collect data on the safety and efficacy of Suturable DuraGen™.
This is a multicenter, non-randomized, non-interventional, retrospective Post-Market Clinical Follow-up (PMCF) study to evaluate the occurrence of post-operative cerebrospinal fluid (CSF) leaks within 30 days (and up to 90 days) after use of Suturable DuraGen™ for a supratentorial, infratentorial, or spinal procedure. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04057157 -
Post-market Assessment of Biodesign Dural Repair Grafts
|
||
Withdrawn |
NCT02902133 -
Acetazolamide to Prevent Post Operative CSF Leak
|
Phase 2 | |
Recruiting |
NCT02927782 -
Mobilisation Algorithm After Incidental Durotomy
|
N/A | |
Completed |
NCT03566602 -
Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
|
N/A | |
Completed |
NCT02891070 -
Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery
|
Phase 3 | |
Recruiting |
NCT04490629 -
The Efficacy and Safety of a Latest Dural Substitute
|
N/A | |
Withdrawn |
NCT04351061 -
Acetazolamide for the Prevention of Post Operative CSF Leak
|
Phase 2 | |
Recruiting |
NCT04086550 -
Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
|
N/A | |
Completed |
NCT02457546 -
The EVICEL® Neurosurgery Phase III Study
|
Phase 3 | |
Completed |
NCT04145544 -
A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.
|
N/A | |
Completed |
NCT04124523 -
Perioperative CSF Leak Management - an Opinion Study
|
||
Withdrawn |
NCT03181464 -
Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics
|
Phase 4 |